@FiercePharma: Special reports this week: Top 11 Fastest-Growing Generics Companies | Top 10 Drug Advertising Spends -- Q1 2012. | Follow @FiercePharma
> Pfizer ($PFE) today announced that Torisel, a drug for renal cell cancer, failed in a late-stage trial in combination with Avastin. Story
> The FDA today approved Marqibo to treat adults with a rare type of leukemia called Philadelphia chromosome negative (Ph-) acute lymphoblastic leukemia (ALL). Release
> Mylan Pharmaceuticals ($MYL) is launching a generic of Cephalon's sleep disorder drug Provigil. Release
> AmerisourceBergen ($ABC) has been subpoenaed in a grand jury investigation into illegal use of controlled substances. Story
> Eli LIlly ($LLY) will take the $1.26 billion in cash it gets from the Amylin sale and invest it in R&D. Story
@FierceMedDev: St. Jude's recalled Riata leads get slapped again. News | Follow @FierceMedDev
@MarkHFierce: BG Medicine has pulled a 510(k) filing for a cardiac disease test. Shockingly, investors weren't happy. Story | Follow @MarkHFierce
@DamianFierce: Despite losing $7M on three recalls, CareFusion posted an income boost for fiscal Q4. News | Follow @DamianFierce
> Luminex scores $11.6M deal for biothreat Dx. Article
> Exact Sciences seeks $50.2M in public offering. More
Biotech News
@FierceBiotech: Nanomaterial propels animals' heart attack-damaged hearts to repair themselves. Article | Follow @FierceBiotech
@JohnCFierce: Sen. Gillibrand wants to create a $200M marketing fund for biotechs. From petri dish to marketplace? Report | Follow @JohnCFierce
@RyanMFierce: Orbimed has backed Intercept Pharma in a $30M C round with lead drug for primary biliary cirrhosis. Release | Follow @RyanMFierce
> Forest makes nice with shareholders ahead of Icahn showdown. Article
> Intercept Pharma snags $30M round amid PhIII for liver-disease drug. News
> Industry Voices: Designing Probiotics - You Get What You Select For. Column
> FDA OKs Talon's drug for rare leukemia. More
And Finally... The CDC says doctors who give Truvada from Gilead Sciences ($GILD) as a preventative for the HIV virus among uninfected homosexual men should be treating gonerrhea differently. Story